Development and Validation of Single-Session Digital Self-Guided Intervention to Prevent Burnout & Improve Wellness
Development and Validation of an Evidence-Based, Self-Guided, Single Session Digital Intervention to Prevent Workplace Burnout & Enhance Psychological Wellness
This study develops and evaluates a self-guided digital single-session mental health intervention designed to reduce workplace burnout and enhance psychological well-being among employed Canadian adults. Workplace burnout, characterized by emotional exhaustion, cynicism, and reduced professional efficacy, affects approximately 40% of Canadian employees and leads to increased absenteeism, reduced productivity, and higher disability claims. Traditional mental health supports face barriers including long wait times, stigma, and accessibility issues. Single-Session Interventions (SSIs) offer a practical, cost-effective, and scalable complement to traditional services.
This is a randomized, double-arm, online trial. Participants are recruited via Prolific and randomly assigned (1:1) to either the experimental single-session burnout intervention or an active control condition focused on creative writing. The intervention focuses on its unique delivery of content focused on the evidence-based techniques, such as cognitive reframing, stress management, and behavioural strategies. The active control matches the intervention in length, structure, and user experience but omits the specific therapeutic ingredients.
All procedures are conducted entirely online through Qualtrics. Participants are compensated for their participation. Participants complete three sessions over approximately 30 days:
A baseline survey (about 10 minutes); A program session and immediate follow-up (about 40 minutes); And a 30-day follow-up survey (about 10 minutes).
Outcome measures include burnout (MBI-16), perceived stress (PSS-10), depressive symptoms (PHQ-8), anxiety (GAD-7), general health (GHQ-12), well-being (WHO-5), work engagement (UWES-3), readiness to change, perceived impact, and program feedback/acceptability. Main outcomes are examined using mixed-effects linear regression with a participant-level random intercept to test the group × time interaction across baseline, post-intervention, and follow-up.
調査の概要
状態
詳細な説明
This study is a randomized, double-arm, online clinical trial evaluating a self-guided, single-session digital intervention for burnout in employed adults. The research is conducted as part of a Ph.D. dissertation of Ehsan Etezad, PhD Candidate in Applied Organizational Psychology at Saint Mary's University under the supervision of Dr. John Fiset (faculty member at Saint Mary's University), with co-investigator Dr. Raghid Al-Hajj (Gulf University for Science and Technology, Kuwait).
The intervention was developed based on a comprehensive systematic review (Phase 1 of the dissertation) that screened 2,349 records and included 27 final studies examining self-guided digital mental health interventions. The design and content of the current intervention are grounded in the best practices identified through that systematic review.
Participants are recruited through Prolific, a third-party online survey panel designed for academic research. The research team posts a study listing that includes a brief description, estimated completion time, compensation, and general eligibility requirements. All recruitment occurs through the Prolific platform with no direct contact between investigators and potential participants.
Eligible participants are presented with an electronic informed consent form describing study procedures, expected time commitment, risks and benefits, confidentiality, voluntary participation, and contact information for the study team and local crisis resources. Consented participants complete a baseline assessment comprising demographic questions and validated outcome measures.
After baseline assessment, participants are randomized (1:1) to the experimental intervention or the active control. Allocation is concealed from participants until they begin their assigned module. The active control condition matches the intervention arm in length, structure, and user experience while intentionally omitting the specific therapeutic ingredients. The active control focuses on creative writing and is non-therapeutic, ensuring that any observed effects can be attributed to the intervention's active components rather than general factors such as time spent, format, attention, or digital engagement. After completing the T3 follow-up survey, all participants in the active control group receive access to the full intervention to ensure equitable access to the intervention's potential benefits.
Data collection occurs at three time points: T1 (baseline), T2 (immediately post-intervention), and T3 (30-day follow-up). The full outcome battery is completed at baseline and immediately post-intervention; follow-up assessments repeat all primary and secondary outcomes to evaluate maintenance of intervention effects.
The main outcomes (burnout, stress, depression, anxiety, wellness, engagement) are examined using mixed-effects linear regression with a participant-level random intercept to test the group × time interaction across baseline, post-intervention, and follow-up. The main comparison focuses on the change from baseline to immediate post-intervention between the two study arms.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Ehsan Etezad
- 電話番号：902-420-5400
- メール：ehsan@ehsanetezad.com
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- 19 years of age or older
- Currently employed full-time
- Reside in Canada
- Not currently receiving treatment for a significant physical or mental health condition (e.g., ongoing psychotherapy or psychiatric care)
- Sufficient English proficiency to understand the intervention materials and complete all study assessments
Exclusion Criteria:
- Being under 19 years of age
- Being unemployed, retired, or a student who is not concurrently employed
- Residing outside Canada
- Currently engaging in significant mental health treatment
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Single-Session Burnout Intervention
A self-guided digital program that delivers evidence-based therapeutic content, including cognitive reframing, stress management, behavioural boundary-setting techniques, and self-care practices.
|
The intervention was developed based on a comprehensive systematic review (Phase 1 of the dissertation) that screened 2,349 records and included 27 final studies examining self-guided digital mental health interventions.
The design and content of the current intervention are grounded in the best practices identified through that systematic review.
Testimonials serve as the core delivery method for the intervention's "active ingredients."
The systematic review showed that testimonials communicate information through narrative, enhance engagement and memory retention, leverage mechanisms such as mirror-neuron activation, reduce resistance, and promote behavioural activation.
Each testimonial is purposefully designed to deliver specific therapeutic content, including cognitive reframing strategies to manage workplace stress, behavioural techniques for setting boundaries, and self-care practices for daily work routines.
|
|
アクティブコンパレータ：Creative Writing
A matched-length, structurally parallel module focused on creative writing.
Matches the intervention in layout, pacing, and aesthetic style but intentionally omits therapeutic ingredients.
|
A matched-length, structurally parallel module focused on creative writing.
Matches the intervention in layout, pacing, and aesthetic style but intentionally omits therapeutic ingredients.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Burnout - Maslach Burnout Inventory (MBI-16)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The Maslach Burnout Inventory-General Survey (MBI-GS) is a 16-item self-report measure of occupational burnout, comprising three subscales: Exhaustion (5 items), Cynicism (5 items), and Professional Efficacy (6 items). Each item is rated on a 7-point frequency scale ranging from 1 ("never") to 7 ("every day"). Subscale scores are calculated as the sum of items within each subscale. Possible ranges are: Exhaustion 5-35, Cynicism 5-35, and Professional Efficacy 6-42. Higher scores on the Exhaustion and Cynicism subscales indicate greater burnout (worse outcome). Higher scores on the Professional Efficacy subscale indicate greater perceived effectiveness (better outcome). |
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Perceived Stress - Perceived Stress Scale (PSS-10)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The Perceived Stress Scale-10 (PSS-10; Cohen, Kamarck, & Mermelstein, 1983) is a 10-item self-report measure of the degree to which situations in one's life are appraised as unpredictable, uncontrollable, and overloaded.
Each item is rated on a 5-point scale from 0 ("never") to 5 ("very often").
Four positively-worded items are reverse-scored prior to summation.
Total scores range from 0 to 50.
Higher scores indicate greater perceived stress (worse outcome).
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Depressive Symptoms - Patient Health Questionnaire (PHQ-8)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The Patient Health Questionnaire-8 (PHQ-8; Kroenke et al., 2009) is an 8-item self-report measure of depressive symptom severity over the past two weeks.
Each item is rated on a 4-point scale from 0 ("not at all") to 3 ("nearly every day").
The total score is the sum of all items.
Total scores range from 0 to 24.
Higher scores indicate greater depressive symptom severity (worse outcome).
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Anxiety - Generalized Anxiety Disorder scale (GAD-7)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006) is a 7-item self-report measure of anxiety symptom severity over the past two weeks.
Each item is rated on a 4-point scale from 0 ("not at all") to 3 ("nearly every day").
The total score is the sum of all items.
Total scores range from 0 to 21.
Higher scores indicate greater anxiety symptom severity (worse outcome).
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
General Health - General Health Questionnaire (GHQ-12)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The General Health Questionnaire-12 (GHQ-12; Goldberg et al., 1997) is a 12-item self-report screen for psychological distress and general mental health over the past few weeks.
Each item is rated on a 4-point response scale (e.g., "more so than usual," "about the same as usual," "less so than usual," "much less than usual").
Items are scored using the Likert method (0-1-2-3 per item), with negatively-worded items reverse-coded so that higher item scores reflect worse health.
Total scores range from 0 to 36.
Higher scores indicate greater psychological distress and worse general mental health (worse outcome).
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Well-Being - WHO Well-Being Index (WHO-5)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The World Health Organization-Five Well-Being Index (WHO-5; WHO, 1998) is a 5-item self-report measure of subjective psychological well-being over the past two weeks.
Each item is rated on a 6-point scale from 0 ("at no time") to 5 ("all of the time").
The raw total score (0-25) is multiplied by 4 to yield a percentage-based score.
Final scores range from 0 to 100.
Higher scores indicate greater subjective well-being (better outcome).
A score below 50 is conventionally considered to indicate reduced well-being.
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Work Engagement - Utrecht Work Engagement Scale (UWES-3)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
The Utrecht Work Engagement Scale-3 (UWES-3; Schaufeli, Shimazu, Hakanen, Salanova, & De Witte, 2019) is a 3-item ultra-short self-report measure of work engagement, with one item each for vigor, dedication, and absorption.
Each item is rated on a 7-point frequency scale from 0 ("never") to 6 ("always / every day").
The total score is computed as the mean of the three items.
The total score ranges from 0 to 6. Higher scores indicate greater work engagement (better outcome).
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Readiness to Change (3-item) Adapted from Motivational Interviewing (Miller & Rollnick, 2013)
時間枠：T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
This measure consists of three single-item "readiness rulers" adapted from the Motivational Interviewing framework (Miller & Rollnick, 2013). Each ruler asks participants to rate, on a 10-point numeric rating scale from 1 to 10, one of the following dimensions of motivation to improve their well-being:
|
T1 - Baseline Pre-Intervention (Day 1); T2 - Post-Intervention Assessment (Day 2); T3 - Follow-up Assessment (Day 30)
|
|
Program Feedback/Acceptability (7-item) Measured by an Adapted Version of the Program Feedback Scale (PFS; Schleider, Dobias, Sung, & Mullarkey, 2020)
時間枠：T2 - Post-Intervention Assessment (Day 2)
|
The Program Feedback Scale (PFS) is a brief self-report measure of program acceptability developed for use with single-session digital interventions.
The version administered in this study contains seven agreement-format items rated on a 5-point Likert scale from 1 ("strongly disagree") to 5 ("strongly agree").
Items include, for example, "I enjoyed the program," "This program was easy to use," "I would recommend this program to a friend going through a hard time," and "I agree with the program's message."The
primary acceptability score is the sum of the seven Likert items, ranging from 7 to 35.
Higher scores indicate greater program acceptability (better outcome).
|
T2 - Post-Intervention Assessment (Day 2)
|
|
Perceived Impact (3-item) Measured by Three Investigator-Developed Anchor-Based Items (Anvari & Lakens, 2021)
時間枠：T2 - Post-Intervention Assessment (Day 2)
|
This measure consists of three investigator-developed items based on the anchor-based methodology described by Anvari and Lakens (2021), used to capture participants' subjective perception of immediate change following the intervention.
Each item asks the participant to rate themselves "compared to before this activity" on a 7-point Likert scale anchored at 1 ("Much Less") and 7 ("Much More"), with the midpoint (4) representing "about the same."
The three items assess perceived change in: (1) confidence in one's ability to manage one's well-being; (2) hopefulness; and (3) confidence in one's ability to solve the problems one is currently facing.
A total score is computed as the sum of the three items, ranging from 3 to 21.
Higher scores indicate a greater perceived positive impact of the intervention (better outcome).
|
T2 - Post-Intervention Assessment (Day 2)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 26-088
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。